
Cat. #162417
Monoclonal antibody anti-MBP (MBP-1H4)
Cat. #: 162417
Target: MALTOSE BINDING PROTEIN (MBP)
Class: Monoclonal
Application: ELISA, WB
Reactivity: N/A
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC)
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Monoclonal antibody anti-MBP (MBP-1H4)
- Research fields: Neurobiology
- Clone: 17TF2-1H4
- Class: Monoclonal
- Conjugation: Unconjugated
- Reactivity: N/A
- Host: Mouse
- Application: ELISA, WB
- Description: Antibody to maltose binding protein with specificity for MBP and MBP fusion proteins
- Immunogen: MBP fusion Protein
- Isotype: IgG1, k
- Additional notes: Avoid repeat freezing and thawing cycles. Does not contain any preservative.
Target Details
- Target: MALTOSE BINDING PROTEIN (MBP)
- Target background: Maltose-Binding Protein (MBP) is primarily a bacterial protein involved in sugar transport, it is often utilized in cancer research as a fusion tag to improve the solubility and expression of recombinant proteins, including those being developed as cancer immunotherapies or targeted delivery systems.
Applications
- Application: ELISA, WB
- Application notes: Available as Crude Ascites Fluid. Recommended dilutions 1/1000-1/5000.
Handling
- Storage conditions: -20°C (up to 3 years)
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)


